| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |